APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digiceutical

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digiceutical Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchDigiceutical Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Digiceutical Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Digiceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digiceutical Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Digiceutical Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Digiceutical market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digiceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digiceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digiceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digiceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digiceutical include Welldoc, Voluntis, Propeller Health, Pear Therapeutics Inc, Chrono Therapeutics Inc. and Akili Interactive Labs, Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digiceutical, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digiceutical, also provides the revenue of main regions and countries. Of the upcoming market potential for Digiceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digiceutical revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digiceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digiceutical revenue, projected growth trends, production technology, application and end-user industry.

Digiceutical Segment by Company

Welldoc

Voluntis

Propeller Health

Pear Therapeutics Inc

Chrono Therapeutics Inc.

Akili Interactive Labs, Inc

Digiceutical Segment by Type

Substance Abuse

Diabetes Management

Neurological Disorders

Alcohol and Smoking Addiction

Pulmonary Diseases

Digiceutical Segment by Application

Medical Device System

Smartphone

Watches

Digiceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digiceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digiceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digiceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digiceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digiceutical company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digiceutical revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digiceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Substance Abuse Major Player Table 3. Diabetes Management Major Player Table 4. Neurological Disorders Major Player Table 5. Alcohol and Smoking Addiction Major Player Table 6. Pulmonary Diseases Major Player Table 7. Global Digiceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Medical Device System Major Player Table 9. Smartphone Major Player Table 10. Watches Major Player Table 11. Digiceutical Industry Trends Table 12. Digiceutical Industry Drivers Table 13. Digiceutical Industry Opportunities and Challenges Table 14. Digiceutical Industry Restraints Table 15. Global Digiceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Digiceutical Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Digiceutical Market Share by Region (2021-2026) Table 18. Global Digiceutical Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Digiceutical Market Share by Region (2027-2032) Table 20. Global Digiceutical Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Digiceutical Revenue Market Share by Players (2021-2026) Table 22. Global Digiceutical Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Digiceutical Key Players Headquarters & Area Served Table 24. Global Digiceutical Players, Product Type & Application Table 25. Global Digiceutical Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Digiceutical by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Digiceutical Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Digiceutical Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Digiceutical Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Digiceutical Revenue Market Share by Type (2021-2026) Table 32. Global Digiceutical Revenue Market Share by Type (2027-2032) Table 33. Global Digiceutical Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Digiceutical Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Digiceutical Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Digiceutical Revenue Market Share by Application (2021-2026) Table 37. Global Digiceutical Revenue Market Share by Application (2027-2032) Table 38. Welldoc Company Information Table 39. Welldoc Business Overview Table 40. Welldoc Digiceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Welldoc Digiceutical Product Portfolio Table 42. Welldoc Recent Development Table 43. Voluntis Company Information Table 44. Voluntis Business Overview Table 45. Voluntis Digiceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Voluntis Digiceutical Product Portfolio Table 47. Voluntis Recent Development Table 48. Propeller Health Company Information Table 49. Propeller Health Business Overview Table 50. Propeller Health Digiceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Propeller Health Digiceutical Product Portfolio Table 52. Propeller Health Recent Development Table 53. Pear Therapeutics Inc Company Information Table 54. Pear Therapeutics Inc Business Overview Table 55. Pear Therapeutics Inc Digiceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Pear Therapeutics Inc Digiceutical Product Portfolio Table 57. Pear Therapeutics Inc Recent Development Table 58. Chrono Therapeutics Inc. Company Information Table 59. Chrono Therapeutics Inc. Business Overview Table 60. Chrono Therapeutics Inc. Digiceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Chrono Therapeutics Inc. Digiceutical Product Portfolio Table 62. Chrono Therapeutics Inc. Recent Development Table 63. Akili Interactive Labs, Inc Company Information Table 64. Akili Interactive Labs, Inc Business Overview Table 65. Akili Interactive Labs, Inc Digiceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Akili Interactive Labs, Inc Digiceutical Product Portfolio Table 67. Akili Interactive Labs, Inc Recent Development Table 68. North America Digiceutical Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Digiceutical Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Digiceutical Revenue by Application (2021-2026) & (US$ Million) Table 71. North America Digiceutical Revenue by Application (2027-2032) & (US$ Million) Table 72. North America Digiceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. North America Digiceutical Revenue by Country (2021-2026) & (US$ Million) Table 74. North America Digiceutical Revenue by Country (US$ Million) & (2027-2032) Table 75. Europe Digiceutical Revenue by Type (2021-2026) & (US$ Million) Table 76. Europe Digiceutical Revenue by Type (2027-2032) & (US$ Million) Table 77. Europe Digiceutical Revenue by Application (2021-2026) & (US$ Million) Table 78. Europe Digiceutical Revenue by Application (2027-2032) & (US$ Million) Table 79. Europe Digiceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. Europe Digiceutical Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Digiceutical Revenue by Country (US$ Million) & (2027-2032) Table 82. China Digiceutical Revenue by Type (2021-2026) & (US$ Million) Table 83. China Digiceutical Revenue by Type (2027-2032) & (US$ Million) Table 84. China Digiceutical Revenue by Application (2021-2026) & (US$ Million) Table 85. China Digiceutical Revenue by Application (2027-2032) & (US$ Million) Table 86. Asia Digiceutical Revenue by Type (2021-2026) & (US$ Million) Table 87. Asia Digiceutical Revenue by Type (2027-2032) & (US$ Million) Table 88. Asia Digiceutical Revenue by Application (2021-2026) & (US$ Million) Table 89. Asia Digiceutical Revenue by Application (2027-2032) & (US$ Million) Table 90. Asia Digiceutical Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 91. Asia Digiceutical Revenue by Region (US$ Million) & (2021-2026) Table 92. Asia Digiceutical Revenue by Region (US$ Million) & (2027-2032) Table 93. SAMEA Digiceutical Revenue by Type (2021-2026) & (US$ Million) Table 94. SAMEA Digiceutical Revenue by Type (2027-2032) & (US$ Million) Table 95. SAMEA Digiceutical Revenue by Application (2021-2026) & (US$ Million) Table 96. SAMEA Digiceutical Revenue by Application (2027-2032) & (US$ Million) Table 97. SAMEA Digiceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. SAMEA Digiceutical Revenue by Country (2021-2026) & (US$ Million) Table 99. SAMEA Digiceutical Revenue by Country (US$ Million) & (2027-2032) Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Digiceutical Image Figure 2. Global Digiceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digiceutical Market Size Share 2021 VS 2025 VS 2032 Figure 4. Substance Abuse Image Figure 5. Diabetes Management Image Figure 6. Neurological Disorders Image Figure 7. Alcohol and Smoking Addiction Image Figure 8. Pulmonary Diseases Image Figure 9. Global Digiceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Digiceutical Market Size Share 2021 VS 2025 VS 2032 Figure 11. Medical Device System Image Figure 12. Smartphone Image Figure 13. Watches Image Figure 14. Global Digiceutical Market Size (US$ Million) & (2021-2032) Figure 15. Global Digiceutical Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Digiceutical Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Digiceutical Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Digiceutical Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Digiceutical Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Digiceutical Revenue Market Share by Type (2021-2032) Figure 22. Global Digiceutical Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Digiceutical Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Digiceutical Revenue Market Share by Application (2021-2032) Figure 25. North America Digiceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Digiceutical Revenue Share by Type (2021-2032) Figure 27. North America Digiceutical Revenue Share by Application (2021-2032) Figure 28. North America Digiceutical Revenue Share by Country (2021-2032) Figure 29. United States Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Digiceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Digiceutical Revenue Share by Type (2021-2032) Figure 34. Europe Digiceutical Revenue Share by Application (2021-2032) Figure 35. Europe Digiceutical Revenue Share by Country (2021-2032) Figure 36. Germany Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Digiceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Digiceutical Revenue Share by Type (2021-2032) Figure 46. China Digiceutical Revenue Share by Application (2021-2032) Figure 47. Asia Digiceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Digiceutical Revenue Share by Type (2021-2032) Figure 49. Asia Digiceutical Revenue Share by Application (2021-2032) Figure 50. Asia Digiceutical Revenue Share by Region (2021-2032) Figure 51. Japan Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Digiceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Digiceutical Revenue Share by Type (2021-2032) Figure 59. SAMEA Digiceutical Revenue Share by Application (2021-2032) Figure 60. SAMEA Digiceutical Revenue Share by Country (2021-2032) Figure 61. Brazil Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Digiceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Substance Abuse
  • Diabetes Management
  • Neurological Disorders
  • Alcohol and Smoking Addiction
  • Pulmonary Diseases
Applications
  • Medical Device System
  • Smartphone
  • Watches
Companies covered
  • Welldoc
  • Voluntis
  • Propeller Health
  • Pear Therapeutics Inc
  • Chrono Therapeutics Inc.
  • Akili Interactive Labs, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digiceutical Market by Type
  3. 1.2.1 Global Digiceutical Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Substance Abuse
  5. 1.2.3 Diabetes Management
  6. 1.2.4 Neurological Disorders
  7. 1.2.5 Alcohol and Smoking Addiction
  8. 1.2.6 Pulmonary Diseases
  9. 1.3 Digiceutical Market by Application
  10. 1.3.1 Global Digiceutical Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Medical Device System
  12. 1.3.3 Smartphone
  13. 1.3.4 Watches
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Digiceutical Market Dynamics
  1. 2.1 Digiceutical Industry Trends
  2. 2.2 Digiceutical Industry Drivers
  3. 2.3 Digiceutical Industry Opportunities and Challenges
  4. 2.4 Digiceutical Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digiceutical Market Perspective (2021-2032)
  2. 3.2 Global Digiceutical Growth Trends by Region
  3. 3.2.1 Global Digiceutical Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digiceutical Market Size by Region (2021-2026)
  5. 3.2.3 Global Digiceutical Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digiceutical Revenue by Players
  2. 4.1.1 Global Digiceutical Revenue by Players (2021-2026)
  3. 4.1.2 Global Digiceutical Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digiceutical Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digiceutical Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digiceutical Key Players Headquarters & Area Served
  7. 4.4 Global Digiceutical Players, Product Type & Application
  8. 4.5 Global Digiceutical Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digiceutical Market CR5 and HHI
  11. 4.6.3 2025 Digiceutical Tier 1, Tier 2, and Tier 3
5 Digiceutical Market Size by Type
  1. 5.1 Global Digiceutical Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digiceutical Revenue by Type (2021-2032)
  3. 5.3 Global Digiceutical Revenue Market Share by Type (2021-2032)
6 Digiceutical Market Size by Application
  1. 6.1 Global Digiceutical Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digiceutical Revenue by Application (2021-2032)
  3. 6.3 Global Digiceutical Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Welldoc
  2. 7.1.1 Welldoc Company Information
  3. 7.1.2 Welldoc Business Overview
  4. 7.1.3 Welldoc Digiceutical Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Welldoc Digiceutical Product Portfolio
  6. 7.1.5 Welldoc Recent Developments
  7. 7.2 Voluntis
  8. 7.2.1 Voluntis Company Information
  9. 7.2.2 Voluntis Business Overview
  10. 7.2.3 Voluntis Digiceutical Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Voluntis Digiceutical Product Portfolio
  12. 7.2.5 Voluntis Recent Developments
  13. 7.3 Propeller Health
  14. 7.3.1 Propeller Health Company Information
  15. 7.3.2 Propeller Health Business Overview
  16. 7.3.3 Propeller Health Digiceutical Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Propeller Health Digiceutical Product Portfolio
  18. 7.3.5 Propeller Health Recent Developments
  19. 7.4 Pear Therapeutics Inc
  20. 7.4.1 Pear Therapeutics Inc Company Information
  21. 7.4.2 Pear Therapeutics Inc Business Overview
  22. 7.4.3 Pear Therapeutics Inc Digiceutical Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pear Therapeutics Inc Digiceutical Product Portfolio
  24. 7.4.5 Pear Therapeutics Inc Recent Developments
  25. 7.5 Chrono Therapeutics Inc.
  26. 7.5.1 Chrono Therapeutics Inc. Company Information
  27. 7.5.2 Chrono Therapeutics Inc. Business Overview
  28. 7.5.3 Chrono Therapeutics Inc. Digiceutical Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Chrono Therapeutics Inc. Digiceutical Product Portfolio
  30. 7.5.5 Chrono Therapeutics Inc. Recent Developments
  31. 7.6 Akili Interactive Labs, Inc
  32. 7.6.1 Akili Interactive Labs, Inc Company Information
  33. 7.6.2 Akili Interactive Labs, Inc Business Overview
  34. 7.6.3 Akili Interactive Labs, Inc Digiceutical Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Akili Interactive Labs, Inc Digiceutical Product Portfolio
  36. 7.6.5 Akili Interactive Labs, Inc Recent Developments
8 North America
  1. 8.1 North America Digiceutical Revenue (2021-2032)
  2. 8.2 North America Digiceutical Revenue by Type (2021-2032)
  3. 8.2.1 North America Digiceutical Revenue by Type (2021-2026)
  4. 8.2.2 North America Digiceutical Revenue by Type (2027-2032)
  5. 8.3 North America Digiceutical Revenue Share by Type (2021-2032)
  6. 8.4 North America Digiceutical Revenue by Application (2021-2032)
  7. 8.4.1 North America Digiceutical Revenue by Application (2021-2026)
  8. 8.4.2 North America Digiceutical Revenue by Application (2027-2032)
  9. 8.5 North America Digiceutical Revenue Share by Application (2021-2032)
  10. 8.6 North America Digiceutical Revenue by Country
  11. 8.6.1 North America Digiceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digiceutical Revenue by Country (2021-2026)
  13. 8.6.3 North America Digiceutical Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digiceutical Revenue (2021-2032)
  2. 9.2 Europe Digiceutical Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digiceutical Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digiceutical Revenue by Type (2027-2032)
  5. 9.3 Europe Digiceutical Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digiceutical Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digiceutical Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digiceutical Revenue by Application (2027-2032)
  9. 9.5 Europe Digiceutical Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digiceutical Revenue by Country
  11. 9.6.1 Europe Digiceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digiceutical Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digiceutical Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digiceutical Revenue (2021-2032)
  2. 10.2 China Digiceutical Revenue by Type (2021-2032)
  3. 10.2.1 China Digiceutical Revenue by Type (2021-2026)
  4. 10.2.2 China Digiceutical Revenue by Type (2027-2032)
  5. 10.3 China Digiceutical Revenue Share by Type (2021-2032)
  6. 10.4 China Digiceutical Revenue by Application (2021-2032)
  7. 10.4.1 China Digiceutical Revenue by Application (2021-2026)
  8. 10.4.2 China Digiceutical Revenue by Application (2027-2032)
  9. 10.5 China Digiceutical Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digiceutical Revenue (2021-2032)
  2. 11.2 Asia Digiceutical Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digiceutical Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digiceutical Revenue by Type (2027-2032)
  5. 11.3 Asia Digiceutical Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digiceutical Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digiceutical Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digiceutical Revenue by Application (2027-2032)
  9. 11.5 Asia Digiceutical Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digiceutical Revenue by Country
  11. 11.6.1 Asia Digiceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digiceutical Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digiceutical Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digiceutical Revenue (2021-2032)
  2. 12.2 SAMEA Digiceutical Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digiceutical Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digiceutical Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digiceutical Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digiceutical Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digiceutical Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digiceutical Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digiceutical Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digiceutical Revenue by Country
  11. 12.6.1 SAMEA Digiceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digiceutical Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digiceutical Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst